top glp-1 drugs for type 2 diabetes 2025 trends 2025: real-world data, patient outcomes & future therapies Compiled and edited by a team of noted pharmacology experts specializing in diabetes care Market Overview: GLP-1 Agonists and

When Vitamin B12 levels are low, these cells dont work well

Taken together, growing evidence demonstrates that the motivational effects of GLP-1RAs on feeding behavior are driven by central neural pathways

Many women worry about what they can and cant do when theyre ready to try again

Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects

Impaired GLP-1 secretion is considered a significant component of the pathology of overweight and obesity, metabolic syndrome and type 2 diabetes, as individuals with these conditions often exhibit reduced GLP-1 release in response to food intake compared to healthy individuals